News from BAT Research & Development
British American Tobacco’s Award Winning 2015 Science & Technology Report details significant strides in the science of tobacco harm reduction made by BAT’s R&D department over the last year.
BAT has won the award for the ‘Most Impressive Public Service Initiative’ at the Global Tobacco and Nicotine Forum (GTNF) conference in Brussels.
Scientists at British American Tobacco used lab-based cellular tests to examine the impact of cigarette smoke and Vype e-cigarette vapour on human lung cells.
In the largest study of its kind, scientists from British American Tobacco and Nicoventures have developed a test to examine vaping behaviour, and then applied it to inform their studies on e-cigarettes.
US-based biotech company IONTOX and British American Tobacco have entered into a collaboration to develop a lung-liver-lung model with a simulated blood system to study the impact of tobacco and nicotine products on lung health.
New research shows that e-cigarettes are as effective at delivering nicotine as conventional cigarettes, especially when used by experienced vapers. In this study, scientists studied changes in blood nicotine from volunteers who used both cigarettes and e-cigarettes. The results revealed that nicotine delivery from e-cigarettes differs, according to the type of e-cigarette, who uses them and how.